John Zurawski

John Zurawski is a licensed patent attorney who combines his patent prosecution background with deep experience in corporate and contract matters to help clients maximize the value and success of their businesses. John provides strategic guidance on business and legal issues, with an emphasis on intellectual property procurement and technology development in the life science and biotechnology industries. John works closely with startups and entrepreneurs, supporting these emerging businesses with 360-degree guidance throughout their commercial lifecycle—including the critical period between formation and early-stage financing.
John routinely prepares, prosecutes, and manages complex patent portfolios focused on biotechnology, molecular biology, immunology, gene therapy, virology, pharmaceuticals, medical devices, diagnostics, stem cells, and biosensors. He provides patentability opinions and performs portfolio diligence for acquisition and sale-side transactions. In addition, John prepares and negotiates agreements for both in- and out-licensing, sponsored research, joint development, clinical research agreements, and other technology-specific commercial contracts.
John advises clients on securing, protecting, commercializing, and managing IP assets, with concentrated experience in exclusivity of patents and regulatory designations for life science companies.
John’s clients include higher education institutions, pharmaceutical companies, and large equipment and vehicle manufacturers. He represents life sciences companies in preclinical and clinical development of diagnostics, therapeutic products, and medical devices. John has deep, direct experience working with higher education clients to protect and manage their IP assets. He teams with university tech transfer and licensing offices to prosecute, license, and manage portfolios of patents in the mechanical, biological, and chemical arts. John is active with the Association of University Technology Managers (AUTM), serving as Chair of the organization’s Eastern Regional Committee.
Prior to attending law school, John worked as a laboratory scientist at the University of Pennsylvania, Drexel University, and a DNA vaccine development company, Apollon, Inc., where he successfully co-authored funded grant applications and journal articles related to therapeutics to treat cancer and HIV infection.